Strategy for managing maternal variant RHD alleles in Rhesus D negative obstetric populations during fetal RHD genotyping

Prenatal Diagnosis

Volumn 34, Issue 1, 2014, Pages 56-62

  Hyland, Catherine A ^a   Gardener, Glenn J ^b   O'Brien, Helen ^a   Millard, Glenda ^a   Gibbons, Kristen ^b   Tremellen, Anne ^b   Ochoa Garay, Gorka ^c   Flower, Robert L ^a   Hyett, Jonathan A ^d  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b MATER MEDICAL RESEARCH INSTITUTE   (Australia)

^c Progenika Inc   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RHESUS D ANTIGEN;

ALLELE; ALLOIMMUNIZATION; ARTICLE; ASIAN; CAUCASIAN; CELL FREE SYSTEM; EXON; FALSE POSITIVE RESULT; FEMALE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GESTATIONAL AGE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MATERNAL BLOOD; MATERNAL PLASMA; PHENOTYPE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; PSEUDOGENE; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; TWIN PREGNANCY;

ALLELES; DNA; FEMALE; FETAL BLOOD; GENETIC VARIATION; GENOTYPING TECHNIQUES; GESTATIONAL AGE; HUMANS; PREGNANCY; RH ISOIMMUNIZATION; RH-HR BLOOD-GROUP SYSTEM;

EID: 84891558187     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4253     Document Type: Article

References (40)

1. Clarke CA. Prevention of Rh-hemolytic disease. Br Med J 1967;4:484-5.
2. Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.
3. Lo YM, Hjelm NM, Fidler C, et al. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N Engl J Med 1998;339:1734-8.
4. Barnicoat A. Medical genetics: advances in brief: presence of fetal DNA in maternal plasma and serum. J Med Genet 1998;35:345.
5. Lo YM, Lau TK, Zhang J, et al. Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem 1999;45:1747-51.
6. Finning KM, Martin PG, Soothill PW, et al. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:1079-85.
7. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann N Y Acad Sci 2004;1022:119-23.
8. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood-a meta-analysis. Am J Obstet Gynecol 2006;195:1163-73.
9. Hyland CA, Gardener GJ, Davies H, et al. Evaluation of non-invasive prenatal RHD genotyping of the fetus. Med J Aust 2009;191:21-5.
10. Moise KJ, Jr., Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012;120:1132-9.
11. Finning K, Martin P, Summers J, et al. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. BMJ 2008;336:816-8.
12. Clausen FB, Christiansen M, Steffensen R, et al. Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis. Transfusion 2012;52:752-8.
13. Wikman AT, Tiblad E, Karlsson A, et al. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012;120:227-34.
14. de Haas M, Van der Schoot C, van der Ploeg C, et al. Noninvasive prenatal screening for RHD in the Netherlands: one test for targeted antenatal and postnatal anti-D prophylaxis. Vox Sang 2012;103:33.
15. Anstee DJ. Red cell genotyping and the future of pretransfusion testing. Blood 2009;114:248-56.
16. Colin Y, Cherif-Zahar B, Le Van Kim C, et al. Genetic basis of the RhD-positive and RhD-negative blood group polymorphism as determined by Southern analysis. Blood 1991;78:2747-52.
17. Daniels G. Rh Blood Group System. In Human Blood Groups, Daniels G (ed.). Oxford: Blackwell Publishing Company, 2002;195-274.
18. Wagner FF, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001;2:10.
19. Faas BH, Beckers EA, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997;37:38-44.
20. Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in Africans with the Rh D-negative blood group phenotype. Blood 2000;95:12-8.
21. Daniels G. Variants of RhD-current testing and clinical consequences. Br J Haematol 2013;161:461-70.
22. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375-87.
23. Shao CP, Maas JH, Su YQ, et al. Molecular background of Rh D-positive, D-negative, D(el) and weak D phenotypes in Chinese. Vox Sang 2002;83:156-61.
24. Wagner FF, Flegel WA. Review: the molecular basis of the Rh blood group phenotypes. Immunohematology 2004;20:23-36.
25. Wagner F. Rhesus Base: D negative and DEL alleles [WWW document] http://www.uni-ulm.de/~fwagner/RH/RB/neg.htm [accessed on 4 July 2013].
26. Avent ND. RHD genotyping from maternal plasma: guidelines and technical challenges. Methods Mol Biol 2008;444:185-201.
27. Grootkerk-Tax MG, Soussan AA, de Haas M, et al. Evaluation of prenatal RHD typing strategies on cell-free fetal DNA from maternal plasma. Transfusion 2006;46:2142-8.
28. Scheffer P, van der Schoot C, Page-Christiaens G, et al. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience. BJOG 2011; 108:1340-8.
29. Flegel WA. Blood group genotyping in Germany. Transfusion 2007;47:47S-53S.
30. Hyland CA, Wolter LC, Saul A. Three unrelated RhD gene polymorphisms identified among blood donors with Rhesus CCee (r'r') phenotypes. Blood 1994;84:321-4.
31. Lo YM. Fetal RhD genotyping from maternal plasma. Ann Med 1999;31:308-12.
32. Avent ND on behalf of the Bloodgen consortium. The Bloodgen project of the European Union. In Progress and Challenges in Transfusion Medicine, Hemostasis, and Hemotherapy, Scharf R (ed.). Düsseldorf: Karger, 2008;178-88.
33. Gardener GJ, Legler TJ, Hyett JA, et al. Anti-D in pregnant women with the RHD(IVS3+1G>A)-associated DEL phenotype. Transfusion 2012;52:2016-9.
34. Kormoczi GF, Gassner C, Shao CP, et al. A comprehensive analysis of DEL types: partial DEL individuals are prone to anti-D alloimmunization. Transfusion 2005;45:1561-7.
35. Flegel WA. Immunogenicity reloaded. Blood 2009;114:3979-80.
36. Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000;95:2699-708.
37. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008;48:2461-75.
38. Shao CP, Xu H, Xu Q, et al. Antenatal Rh prophylaxis is unnecessary for " Asia type" DEL women. Transfus Clin Biol 2010;17:260-4.
39. Shao CP. Transfusion of RhD-positive blood in "Asia type" DEL recipients. N Engl J Med 2010;362:472-3.
40. Liu HC, Eng HL, Yang YF, et al. Aberrant RNA splicing in RHD 7-9 exons of DEL individuals in Taiwan: a mechanism study. Biochim Biophys Acta 2010;1800:565-73.